The Pilot Project Component is designed to provide a flexible means for developing and exploring new? research activities or directions, and unique opportunities that can evolve into independently funded? research projects. In addition, the Pilot Project Component provides a resource for attracting new? investigators into drug abuse research. We propose to fund an average of three pilot projects per year with? an average budget of $33K. The expected duration of these pilot projects will be 1-2 years. The Center? Scientific Director will manage this Component. Pilot Project Component applications will be solicited from all? OHSU- and Portland VA Medical Center-based investigators annually. Each proposal will be evaluated for? scientific merit/innovation, thematic alignment and several other criteria by at least two members of the? Center's Scientific Advisory Board, the Scientific Director, and the Center Director. Recommendations for? funding will be considered for approval by the Center Executive Committee. Three pilot projects are? proposed for funding in Year 1 of the Methamphetamine Abuse Research Center (MARC). Project 8A (W.? Hoffman, PI) will use functional magnetic resonance imaging to study neuroanatomical associates of MA? addiction and heightened impulsivity. Project 8B (S. Mitchell, PI) will examine in mice the notion that? impulsivity is related to MA self-administration, using a delay discounting procedure. Project 8C (J. Raber,? PI) will explore the hypothesis that histamine mediates the detrimental long-term effects of neonatal MA? exposure on cognition. All of these pilots are related to a Center theme at least by virtue of their examination? of MA effects. In addition, mice used in Project 8B and 8C will share genetic background with those used in? Scientific Components 5 and 6, and will obtain mice from the Animal Core. Pilot project 8A also relates to the? Center impulsivity, neuroadaptation and neuroanatomy themes; Pilot project 8B relates to the Center? impulsivity theme; and Pilot project 8C relates to the Center stressor responsivity and neuroadaptation? themes. It is expected that Pilot Component projects funded in years 2-5 of the Center will contribute to the? study of MA abuse and to one or more of the additional themes of the Center: Impulsivity, stressor? responsivity, neuroadaptation, and neuroanatomy, and to our goal of pursuing translational research in? preclinical and clinical models.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
United States
Zip Code
Shabani, Shkelzen; Schmidt, Bryan; Ghimire, Bikalpa et al. (2018) Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. Genes Brain Behav :e12533
Eshleman, Amy J; Nagarajan, Shanthi; Wolfrum, Katherine M et al. (2018) Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Psychopharmacology (Berl) :
McCready, Holly; Kohno, Milky; Kolessar, Michael et al. (2018) Functional MRI and delay discounting in patients infected with hepatitis C. J Neurovirol 24:738-751
Loftis, Jennifer M; Valerio, Juno; Taylor, Jonathan et al. (2018) S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcohol Clin Exp Res :
Eshleman, Amy J; Wolfrum, Katherine M; Reed, John F et al. (2018) Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors. Biochem Pharmacol 158:27-34
Tosh, Dilip K; Ciancetta, Antonella; Mannes, Philip et al. (2018) Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega 3:12658-12678
McCarty, Dennis; Priest, Kelsey C; Korthuis, P Todd (2018) Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities. Annu Rev Public Health 39:525-541
Eastwood, Emily C; Eshleman, Amy J; Janowsky, Aaron et al. (2018) Verification of a genetic locus for methamphetamine intake and the impact of morphine. Mamm Genome 29:260-272
Kohno, Milky; Dennis, Laura E; McCready, Holly et al. (2018) A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder. Drug Alcohol Depend 192:186-192
Holton, Dwight; White, Elizabeth; McCarty, Dennis (2018) Public Health Policy Strategies to Address the Opioid Epidemic. Clin Pharmacol Ther 103:959-962

Showing the most recent 10 out of 143 publications